Clinical Trials Logo

Clinical Trial Summary

This is a prospective implementation study that will include patients that are identified as being average risk for colorectal cancer (CRC) according to USPSTF guidelines and who have opted to be screened for CRC. The purpose of this study is to understand implementation of a noninvasive screening test in primary care and internal medicine clinical settings, and the impact on patient acceptability and adherence of CRC screening.


Clinical Trial Description

Study Rationale This is a prospective implementation study that will include patients that are identified as being average risk for colorectal cancer (CRC) according to USPSTF guidelines and who have opted to be screened for CRC. The purpose of this study is to understand implementation of a noninvasive screening test in primary care and internal medicine clinical settings, and the impact on patient acceptability and adherence of CRC screening. Although multiple screening options for CRC are available, participation and adherence to CRC screening remains below the national goal. CRC screening rate at the Ballad Health Mountain Laurel Internal Medicine clinic (site 1) is approximately 66%. A blood-based test (BBT) can provide a clinically important complement to standard-of-care (SOC) screening tests and address unmet medical needs for patients, especially for those who are non-adherent with current screening modalities. There are economic and societal benefits in early detection and prevention of CRC in a broader population than the one currently up to date with screening. The unmet need for maximum participation in CRC screening could be addressed with blood-based testing. Measuring subsequent provider experience and implementation behavior patterns involving blood based non-invasive cancer screening choices will also help to identify clinical utility of such test and implementation into clinical practice. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06119425
Study type Interventional
Source Ballad Health
Contact Charlie Mayes, PhD
Phone 423-431-5654
Email Charles.Mays@balladhealth.org
Status Recruiting
Phase N/A
Start date October 12, 2023
Completion date October 31, 2024

See also
  Status Clinical Trial Phase
Completed NCT03179358 - Clinical Trial Verifying C-REX LapAid and C-REX DMH/DMHC N/A
Recruiting NCT03976960 - Clinical and Biological Database in Colon Cancer and Colic Tumors N/A
Not yet recruiting NCT04079946 - The Efficacy Of Complete Mesocolic Excision With Central Vessel Ligation Technique On Lymph Nodes And Safety Margins Compared With Conventional Surgery For Colon Cancer Treatment N/A
Recruiting NCT05177484 - Perioperative Iron for Colorectal Cancer (PICoC Study) Phase 3
Completed NCT03951792 - Time Longitudinal Study of the Microbiome in Colorectal Cancer Subjects
Recruiting NCT06391749 - Clinical Validation of an MCED Test in Symptomatic Populations (K-ACCELERATE)
Recruiting NCT03722121 - Is the Distance of Patients From Rouen University Hospital Influencing the Time Between Colectomy and First Chemotherapy Cure for Colon Cancer?
Not yet recruiting NCT05154474 - Assessment of Sarcopenia at Diagnosis for Patients With Previously Untreated Metastatic Cancer or Hematologic Malignancy
Recruiting NCT04972994 - Laparoscopic Colectomies In Management of Colonic Cancers N/A
Recruiting NCT02542670 - Genetic Variants of Selected Genes in Colo-Rectal Cancer Patients. N/A
Completed NCT03688906 - AI-EMERGE: Development and Validation of a Multi-analyte, Blood-based Colorectal Cancer Screening Test
Completed NCT05225870 - Significance of Cortactin Expression in Colorectal Adenocarcinomas N/A
Completed NCT04400552 - Perioperative Oral Nutrition Supplementation in Malnourished Surgical Cancer Patients N/A
Withdrawn NCT03185416 - Early Palliative Care Integration in Interventional Cancer Care N/A
Completed NCT01533090 - Evaluation of Reduced-volume PEG Bowel Preparation Administered the Same Day of Colonoscopy N/A